TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,694 | -50.5% | 114,482 | -46.4% | 0.00% | – |
| Q2 2023 | $649,813 | -66.9% | 213,754 | -79.5% | 0.00% | – |
| Q1 2023 | $1,964,837 | -45.3% | 1,045,126 | -70.3% | 0.00% | -100.0% |
| Q4 2022 | $3,592,581 | -48.7% | 3,522,138 | +32.3% | 0.00% | -50.0% |
| Q3 2022 | $7,002,000 | -41.9% | 2,662,566 | -0.4% | 0.00% | -33.3% |
| Q2 2022 | $12,053,000 | -54.0% | 2,672,474 | +0.3% | 0.00% | -40.0% |
| Q1 2022 | $26,209,000 | -35.6% | 2,663,593 | +0.1% | 0.01% | -37.5% |
| Q4 2021 | $40,696,000 | +14.9% | 2,661,636 | -0.3% | 0.01% | +14.3% |
| Q3 2021 | $35,406,000 | -7.2% | 2,669,466 | -0.0% | 0.01% | -22.2% |
| Q2 2021 | $38,146,000 | – | 2,670,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |